top of page

Values in Rs. in  Crores

Pfizer Sep 23 Revenue as compared to Sep,22 Shrinks by 9.8% to Rs.575 Crore and Year on Year Profit plunge by 52.1% to Rs.149 Crore. Quarter to Quarter Revenue Increases by 8.3% and Q to Q Profit jumps by 59.3%

00:00 / 03:48
download (4).png

Revenue Analysis:

Pfizer, has reported a revenue of Rs. 575 Crore, which has lessen by 8.3% as compared to previous quarter revenue of Rs. 531 Crore. As compared to revenue of September-22, there is a drops by -9.8% from Rs. 637 Crore. to Rs. 575 Crore.


Profit and Cost Analysis

Quarterly Profit has drastically reduces by 52.1% to Rs.149 Crore from Rs. 311 Crore, when compared with year ago quarter results. In comparison with preceding quarter of June, 2023 , quarter profit has increases sharply by 59.3% to Rs.149 Crore from Rs. 94 Crore. Net Profit % of the Company has remained at 25.9% compared to 17.6% in previous quarter and 48.8% in year ago quarter.

On analysis, it is observed that this Quarter's EBITDA (Operating Profit) Margin has grown to 31.7% from 20.8% as compared with June, 2023 quarter. The reason for the rise of EBITDA Margin is due to,

a) Cost of Sales has diminish to 35.6% (Previous Quarter: 40.6%). Cost of Sales in absolute terms has drops from Rs. 216 Crore to 205 Crore.

b) Employee Cost has shrinks to 15.6% (Previous Quarter: 17.6%). Employee Cost in exact value has dwindle from Rs. 94 Crore to 90 Crore.

c) Other Expenses has decreases sharply to 17.0% (Previous Quarter: 20.9%). Other Expenses slides from Rs. 111 Crore to 98 Crore.

The finance cost has lessen from Rs. 2.87 Crore to 2.73 Crore by -4.9%.


Key Matrix:

Price to Earning (PE) ratio of the company is 26.29 as compared to the Industry PE of 43.47. Low PE signifies that there can be scope of increase in share prices in future. Companies Return on Equity (ROE) is 16.0% and Return of Capital Employed (ROCE) is 22.1%.


Share Price Movement:

The Return on Share Prices were 2.0% in past one month, -1.5% in 3 months, 4.6% in 6 months, -10.1% in 12 months, -22.0% in 24 months.


Summary:

To summarize, as compared to June'23, Revenue has increases by 8.3%. Gross Margin has increases from 59.4% to 64.4%. EBITDA Margin has grown to 31.7% from 20.8%. and Net Profit After Tax Margin has increases sharply to 25.9% from 17.6%.


The Brief of Quarterly Results is as follows:



Pfizer Ltd.,

Particulars (In Cr.)
Sep, 2023
Jun, 2023
Mar, 2023
Dec, 2022
Revenue
575
531
573
622
Cost of Goods Sold
205
216
216
217
Employee Cost
90
94
65
92
Other Expenses
98
111
109
109
EBITDA
183
111
182
203
Depreciation
15
16
26
26
Interest Expense
3
3
3
4
Other Income
36
33
31
27
Profit B4 Excep. Items
201
126
184
201
Exception Items
0
20
0
Net Profit Before Tax
201
126
165
201
Taxes
52
32
35
50
Net Profit After Tax
149
94
130
151
Gross Margin %
64.40%
59.40%
62.30%
65.10%
Employee Cost %
15.60%
17.60%
11.40%
14.70%
Other Expense Cost %
17.00%
20.90%
19.10%
17.60%
EBITDA %
31.70%
20.80%
31.80%
32.70%
Net Profit After Tax %
25.90%
17.60%
22.60%
24.20%

Blue Dart Sep 23 Revenue as compared to Sep,22 Nearly Maintains by 0.1% to Rs.1324 Crore and Year on Year Profit turndowns by 22.0% to Rs.73 Crore. Quarter to Quarter Revenue Surge by 7.0% and Q to Q Profit increases sharply by 19.2%

00:00 / 03:44

Reliance Sep 23 Revenue as compared to Sep,22 Nearly Maintains by 0.9% to Rs.234956 Crore and Year on Year Profit flies by 28.2% to Rs.19878 Crore. Quarter to Quarter Revenue Surge by 11.4% and Q to Q Profit grown by 8.9%

00:00 / 03:57

JUBILANT PHARMOVA Sep 23 Revenue as compared to Sep,22 Zooms by 5.1% to Rs.1680 Crore and Year on Year Profit zooms by 1162.2% to Rs.62 Crore. Quarter to Quarter Revenue Zooms by 5.9% and Q to Q Profit spikes by 935.0%

00:00 / 04:24

Cipla Sep'23 Revenue as compared to Sep'22 Zooms by 14.6% to Rs.6678 Crore and Year on Year Profit zooms by 44.8% to Rs.1155 Crore. Quarter to Quarter Revenue Balloons by 16.4% and Q to Q Profit spikes by 121.4%

00:00 / 04:07

Maruti Suzuki Sep 23 Revenue as compared to Sep,22 Jumps by 23.8% to Rs.37073 Crore and Year on Year Profit flies by 78.2% to Rs.3764 Crore. Quarter to Quarter Revenue Surge by 14.6% and Q to Q Profit increases sharply by 49.1%

00:00 / 04:10
bottom of page